Sweden-based global medtech company Getinge is going to acquire 100% of US-based organ transport products and services company Paragonix Technologies, for approximately $477 million.
US-based global investment company KKR, private equity firm TPG Capital, and British private equity firm Apax Partners are reportedly exploring an investment in India’s Sahajanand Medical Technologies (SMT), Economic Times reported. SMT is a developer and manufacturer of minimally invasive coronary stent systems, valued at Rs 3,500-4,000 crore (~$420-480 million USD). Alongside KKR, TPG Capital, […]
At last year’s conference Hedley Goldberg, Managing Director at multinational investment bank Rothschild, predicted healthcare M&A activity would begin picking up again in Q4 2023 or Q1 2024. But we’re now halfway through 2024 and there are still very few deals above €500m taking place. Goldberg is confident, however, that we have now passed through the bottom of the cycle.
NMC Health Plc’s administrators have started selling off parts of the business according to Bloomberg with an auction of the fertility business as early as June. Consultants Alvarez & Marsal who are handling the business have invited bids for NMC’s distribution business according to the article. Potential acquirers have been asked to submit offers this […]
In the second of our two-part deep dive into how COVID-19 is hitting healthcare markets across EMEA, we ask how hospitals are coping with spiralling staff sickness and a flood of patients, and whether the care and dialysis sectors can stay afloat given the risk the virus poses to their most vulnerable patients.
How has French drugs delivery start-up Otzii established itself on a market where it is illegal to make money from the sale of medication unless you're a pharmacist?
Stripping away M&A and financial things like indebtedness, all for-profit healthcare businesses will succeed or fail based on these three parameters. And all can be measured along them, too.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.OkCookies Policy
